Cite
Kosakowska E, Pietrzak L, Michalski W, et al. Neoadjuvant chemotherapy with or without oxaliplatin after short-course radiotherapy in high-risk rectal cancer: A subgroup analysis from a prospective study. Rep Pract Oncol Radiother. 2020;25(6):1017-1022doi: 10.1016/j.rpor.2020.08.002.
Kosakowska, E., Pietrzak, L., Michalski, W., Kepka, L., Polkowski, W., Jankiewicz, M., Cisel, B., Krynski, J., Zwolinski, J., Wyrwicz, L., Rutkowski, A., Stylinski, R., Nawrocki, G., Sopylo, R., Szczepkowski, M., Tarnowski, W., Bujko, K. (2020). Neoadjuvant chemotherapy with or without oxaliplatin after short-course radiotherapy in high-risk rectal cancer: A subgroup analysis from a prospective study. Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology, 25(6), 1017-1022. https://doi.org/10.1016/j.rpor.2020.08.002
Kosakowska, Ewa, et al. "Neoadjuvant chemotherapy with or without oxaliplatin after short-course radiotherapy in high-risk rectal cancer: A subgroup analysis from a prospective study." Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology vol. 25,6 (2020): 1017-1022. doi: https://doi.org/10.1016/j.rpor.2020.08.002
Kosakowska E, Pietrzak L, Michalski W, Kepka L, Polkowski W, Jankiewicz M, Cisel B, Krynski J, Zwolinski J, Wyrwicz L, Rutkowski A, Stylinski R, Nawrocki G, Sopylo R, Szczepkowski M, Tarnowski W, Bujko K. Neoadjuvant chemotherapy with or without oxaliplatin after short-course radiotherapy in high-risk rectal cancer: A subgroup analysis from a prospective study. Rep Pract Oncol Radiother. 2020 Nov-Dec;25(6):1017-1022. doi: 10.1016/j.rpor.2020.08.002. Epub 2020 Aug 16. PMID: 33390858; PMCID: PMC7772602.
Copy
Download .nbib